Development and Validation of Nomograms to Predict the Prognosis of Patients With Unresectable Hepatocellular Carcinoma Receiving Transarterial Chemoembolization
Background: Recent studies have shown that inflammatory indicators are closely related to the prognosis of patients with hepatocellular carcinoma, and they can serve as powerful indices for predicting recurrence and survival time after treatment. However, the predictive ability of inflammatory indic...
Main Authors: | Dongxu Zhao, Wei Xu, Yi Zhan, Lin Xu, Wenbin Ding, Aibing Xu, Zhongheng Hou, Caifang Ni |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-06-01
|
Series: | Clinical Medicine Insights: Oncology |
Online Access: | https://doi.org/10.1177/11795549231178178 |
Similar Items
-
Development and Validation of a Prognostic Model for Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma Based on Preoperative Serum Prealbumin
by: Xu L, et al.
Published: (2023-12-01) -
Outcome of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma
by: Hadeel A Helmi, et al.
Published: (2020-01-01) -
Transarterial Chemoembolization for Patients with Unresectable Hepatocellular Carcinoma with Child-Pugh B7
by: Jiang JQ, et al.
Published: (2023-09-01) -
Regorafenib combined with transarterial chemoembolization for unresectable hepatocellular carcinoma: a real-world study
by: Yue Han, et al.
Published: (2021-10-01) -
Factors Predicting Survival after Transarterial Chemoembolization of Unresectable Hepatocellular Carcinoma
by: Farina M. Hanif, et al.
Published: (2014-10-01)